series-a
Stage
2018
Founded
3
Investors
About
NETRIS PHARMA SAS develops radiopharmaceutical compounds for medical imaging and targeted therapy in the pharmaceutical sector.
Explore NETRIS PHARMA SAS's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.